 | • レポートコード：QFJ1-4291 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、心不全治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、手術治療）、用途別市場規模（急性心不全、慢性心不全）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・心不全治療の市場動向 ・企業の競争状況、市場シェア ・心不全治療の種類別市場規模と予測2016-2027（薬物治療、手術治療） ・心不全治療の用途別市場規模と予測2016-2027（急性心不全、慢性心不全） ・心不全治療の北米市場規模2016-2027（アメリカ、カナダ） ・心不全治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・心不全治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・心不全治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・心不全治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis、Merck、Sanofi、Johnson & Johnson、AstraZeneca、GlaxoSmithKline、Amgen、Bayer、BMS、Cardiorentis、Cytokinetics、Ono Pharmaceuticals、Mylan、NCPC、Xinhua Group、Xudong Haipu Pharmaceutical） ・結論 |
The main treatment for heart failure is etiological treatment.Because heart failure is the ultimate state of the heart, the causes of heart failure are different.Some people may have hyperthyroidism induced heart failure, and the treatment plan is to actively correct hyperthyroidism.Some people because arrhythmia causes tachycardia, cardiomyopathy, control arrhythmia, heart failure will improve naturally.There are still some people who have heart failure caused by ischemic heart disease. They need coronary angiography to actively change the state of heart ischemia, and heart failure can be recovered to a certain extent.There are other diseases, so the etiology of heart failure is important.If heart failure occurs, take active medication.Above all, want to use the therapeutics of heart failure normatively, strong heart, diuresis, dilate blood-vessel is a few treatment means to heart failure acute period, can alleviate improve the symptom of the patient.Chronic treatment of heart failure requires the long-term use of ACEI or ARB, beta blockers and diuretic drugs to reduce the length of hospital stay in patients with heart failure and improve their quality of life, as well as three-chamber pacemaker implantation and heart transplantation.
Market Analysis and Insights: Global Heart Failure Treatment Market
The global Heart Failure Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Heart Failure Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Heart Failure Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Heart Failure Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Heart Failure Treatment market.
Global Heart Failure Treatment Scope and Market Size
Heart Failure Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Heart Failure Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Drug Treatment
Surgical Treatment
Segment by Application
Acute Heart Failure
Chronic Heart Failure
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Novartis
Merck
Sanofi
Johnson & Johnson
AstraZeneca
GlaxoSmithKline
Amgen
Bayer
BMS
Cardiorentis
Cytokinetics
Ono Pharmaceuticals
Mylan
NCPC
Xinhua Group
Xudong Haipu Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Heart Failure Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Drug Treatment
1.2.3 Surgical Treatment
1.3 Market by Application
1.3.1 Global Heart Failure Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Acute Heart Failure
1.3.3 Chronic Heart Failure
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Heart Failure Treatment Market Perspective (2016-2027)
2.2 Heart Failure Treatment Growth Trends by Regions
2.2.1 Heart Failure Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Heart Failure Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Heart Failure Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Heart Failure Treatment Industry Dynamic
2.3.1 Heart Failure Treatment Market Trends
2.3.2 Heart Failure Treatment Market Drivers
2.3.3 Heart Failure Treatment Market Challenges
2.3.4 Heart Failure Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Heart Failure Treatment Players by Revenue
3.1.1 Global Top Heart Failure Treatment Players by Revenue (2016-2021)
3.1.2 Global Heart Failure Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Heart Failure Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Heart Failure Treatment Revenue
3.4 Global Heart Failure Treatment Market Concentration Ratio
3.4.1 Global Heart Failure Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Heart Failure Treatment Revenue in 2020
3.5 Heart Failure Treatment Key Players Head office and Area Served
3.6 Key Players Heart Failure Treatment Product Solution and Service
3.7 Date of Enter into Heart Failure Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Heart Failure Treatment Breakdown Data by Type
4.1 Global Heart Failure Treatment Historic Market Size by Type (2016-2021)
4.2 Global Heart Failure Treatment Forecasted Market Size by Type (2022-2027)
5 Heart Failure Treatment Breakdown Data by Application
5.1 Global Heart Failure Treatment Historic Market Size by Application (2016-2021)
5.2 Global Heart Failure Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Heart Failure Treatment Market Size (2016-2027)
6.2 North America Heart Failure Treatment Market Size by Type
6.2.1 North America Heart Failure Treatment Market Size by Type (2016-2021)
6.2.2 North America Heart Failure Treatment Market Size by Type (2022-2027)
6.2.3 North America Heart Failure Treatment Market Size by Type (2016-2027)
6.3 North America Heart Failure Treatment Market Size by Application
6.3.1 North America Heart Failure Treatment Market Size by Application (2016-2021)
6.3.2 North America Heart Failure Treatment Market Size by Application (2022-2027)
6.3.3 North America Heart Failure Treatment Market Size by Application (2016-2027)
6.4 North America Heart Failure Treatment Market Size by Country
6.4.1 North America Heart Failure Treatment Market Size by Country (2016-2021)
6.4.2 North America Heart Failure Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Heart Failure Treatment Market Size (2016-2027)
7.2 Europe Heart Failure Treatment Market Size by Type
7.2.1 Europe Heart Failure Treatment Market Size by Type (2016-2021)
7.2.2 Europe Heart Failure Treatment Market Size by Type (2022-2027)
7.2.3 Europe Heart Failure Treatment Market Size by Type (2016-2027)
7.3 Europe Heart Failure Treatment Market Size by Application
7.3.1 Europe Heart Failure Treatment Market Size by Application (2016-2021)
7.3.2 Europe Heart Failure Treatment Market Size by Application (2022-2027)
7.3.3 Europe Heart Failure Treatment Market Size by Application (2016-2027)
7.4 Europe Heart Failure Treatment Market Size by Country
7.4.1 Europe Heart Failure Treatment Market Size by Country (2016-2021)
7.4.2 Europe Heart Failure Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Heart Failure Treatment Market Size (2016-2027)
8.2 Asia-Pacific Heart Failure Treatment Market Size by Type
8.2.1 Asia-Pacific Heart Failure Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Heart Failure Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Heart Failure Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Heart Failure Treatment Market Size by Application
8.3.1 Asia-Pacific Heart Failure Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Heart Failure Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Heart Failure Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Heart Failure Treatment Market Size by Region
8.4.1 Asia-Pacific Heart Failure Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Heart Failure Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Heart Failure Treatment Market Size (2016-2027)
9.2 Latin America Heart Failure Treatment Market Size by Type
9.2.1 Latin America Heart Failure Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Heart Failure Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Heart Failure Treatment Market Size by Type (2016-2027)
9.3 Latin America Heart Failure Treatment Market Size by Application
9.3.1 Latin America Heart Failure Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Heart Failure Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Heart Failure Treatment Market Size by Application (2016-2027)
9.4 Latin America Heart Failure Treatment Market Size by Country
9.4.1 Latin America Heart Failure Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Heart Failure Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Heart Failure Treatment Market Size (2016-2027)
10.2 Middle East & Africa Heart Failure Treatment Market Size by Type
10.2.1 Middle East & Africa Heart Failure Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Heart Failure Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Heart Failure Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Heart Failure Treatment Market Size by Application
10.3.1 Middle East & Africa Heart Failure Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Heart Failure Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Heart Failure Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Heart Failure Treatment Market Size by Country
10.4.1 Middle East & Africa Heart Failure Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Heart Failure Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Heart Failure Treatment Introduction
11.1.4 Pfizer Revenue in Heart Failure Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Heart Failure Treatment Introduction
11.2.4 Novartis Revenue in Heart Failure Treatment Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Heart Failure Treatment Introduction
11.3.4 Merck Revenue in Heart Failure Treatment Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Heart Failure Treatment Introduction
11.4.4 Sanofi Revenue in Heart Failure Treatment Business (2016-2021)
11.4.5 Sanofi Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Heart Failure Treatment Introduction
11.5.4 Johnson & Johnson Revenue in Heart Failure Treatment Business (2016-2021)
11.5.5 Johnson & Johnson Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Heart Failure Treatment Introduction
11.6.4 AstraZeneca Revenue in Heart Failure Treatment Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Heart Failure Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Heart Failure Treatment Business (2016-2021)
11.7.5 GlaxoSmithKline Recent Development
11.8 Amgen
11.8.1 Amgen Company Details
11.8.2 Amgen Business Overview
11.8.3 Amgen Heart Failure Treatment Introduction
11.8.4 Amgen Revenue in Heart Failure Treatment Business (2016-2021)
11.8.5 Amgen Recent Development
11.9 Bayer
11.9.1 Bayer Company Details
11.9.2 Bayer Business Overview
11.9.3 Bayer Heart Failure Treatment Introduction
11.9.4 Bayer Revenue in Heart Failure Treatment Business (2016-2021)
11.9.5 Bayer Recent Development
11.10 BMS
11.10.1 BMS Company Details
11.10.2 BMS Business Overview
11.10.3 BMS Heart Failure Treatment Introduction
11.10.4 BMS Revenue in Heart Failure Treatment Business (2016-2021)
11.10.5 BMS Recent Development
11.11 Cardiorentis
11.11.1 Cardiorentis Company Details
11.11.2 Cardiorentis Business Overview
11.11.3 Cardiorentis Heart Failure Treatment Introduction
11.11.4 Cardiorentis Revenue in Heart Failure Treatment Business (2016-2021)
11.11.5 Cardiorentis Recent Development
11.12 Cytokinetics
11.12.1 Cytokinetics Company Details
11.12.2 Cytokinetics Business Overview
11.12.3 Cytokinetics Heart Failure Treatment Introduction
11.12.4 Cytokinetics Revenue in Heart Failure Treatment Business (2016-2021)
11.12.5 Cytokinetics Recent Development
11.13 Ono Pharmaceuticals
11.13.1 Ono Pharmaceuticals Company Details
11.13.2 Ono Pharmaceuticals Business Overview
11.13.3 Ono Pharmaceuticals Heart Failure Treatment Introduction
11.13.4 Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2016-2021)
11.13.5 Ono Pharmaceuticals Recent Development
11.14 Mylan
11.14.1 Mylan Company Details
11.14.2 Mylan Business Overview
11.14.3 Mylan Heart Failure Treatment Introduction
11.14.4 Mylan Revenue in Heart Failure Treatment Business (2016-2021)
11.14.5 Mylan Recent Development
11.15 NCPC
11.15.1 NCPC Company Details
11.15.2 NCPC Business Overview
11.15.3 NCPC Heart Failure Treatment Introduction
11.15.4 NCPC Revenue in Heart Failure Treatment Business (2016-2021)
11.15.5 NCPC Recent Development
11.16 Xinhua Group
11.16.1 Xinhua Group Company Details
11.16.2 Xinhua Group Business Overview
11.16.3 Xinhua Group Heart Failure Treatment Introduction
11.16.4 Xinhua Group Revenue in Heart Failure Treatment Business (2016-2021)
11.16.5 Xinhua Group Recent Development
11.17 Xudong Haipu Pharmaceutical
11.17.1 Xudong Haipu Pharmaceutical Company Details
11.17.2 Xudong Haipu Pharmaceutical Business Overview
11.17.3 Xudong Haipu Pharmaceutical Heart Failure Treatment Introduction
11.17.4 Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2016-2021)
11.17.5 Xudong Haipu Pharmaceutical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Heart Failure Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Drug Treatment
Table 3. Key Players of Surgical Treatment
Table 4. Global Heart Failure Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Heart Failure Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Heart Failure Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Heart Failure Treatment Market Share by Regions (2016-2021)
Table 8. Global Heart Failure Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Heart Failure Treatment Market Share by Regions (2022-2027)
Table 10. Heart Failure Treatment Market Trends
Table 11. Heart Failure Treatment Market Drivers
Table 12. Heart Failure Treatment Market Challenges
Table 13. Heart Failure Treatment Market Restraints
Table 14. Global Heart Failure Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Heart Failure Treatment Market Share by Players (2016-2021)
Table 16. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Treatment as of 2020)
Table 17. Ranking of Global Top Heart Failure Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Heart Failure Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Heart Failure Treatment Product Solution and Service
Table 21. Date of Enter into Heart Failure Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Heart Failure Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Heart Failure Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Heart Failure Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Heart Failure Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Heart Failure Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Heart Failure Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Heart Failure Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Heart Failure Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Heart Failure Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Heart Failure Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Heart Failure Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Heart Failure Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Heart Failure Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Heart Failure Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Heart Failure Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Heart Failure Treatment Product
Table 64. Pfizer Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Novartis Company Details
Table 67. Novartis Business Overview
Table 68. Novartis Heart Failure Treatment Product
Table 69. Novartis Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 70. Novartis Recent Development
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Heart Failure Treatment Product
Table 74. Merck Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 75. Merck Recent Development
Table 76. Sanofi Company Details
Table 77. Sanofi Business Overview
Table 78. Sanofi Heart Failure Treatment Product
Table 79. Sanofi Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 80. Sanofi Recent Development
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Heart Failure Treatment Product
Table 84. Johnson & Johnson Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 85. Johnson & Johnson Recent Development
Table 86. AstraZeneca Company Details
Table 87. AstraZeneca Business Overview
Table 88. AstraZeneca Heart Failure Treatment Product
Table 89. AstraZeneca Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 90. AstraZeneca Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Heart Failure Treatment Product
Table 94. GlaxoSmithKline Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 99. Amgen Recent Development
Table 100. Bayer Company Details
Table 101. Bayer Business Overview
Table 102. Bayer Heart Failure Treatment Product
Table 103. Bayer Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 104. Bayer Recent Development
Table 105. BMS Company Details
Table 106. BMS Business Overview
Table 107. BMS Heart Failure Treatment Product
Table 108. BMS Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 109. BMS Recent Development
Table 110. Cardiorentis Company Details
Table 111. Cardiorentis Business Overview
Table 112. Cardiorentis Heart Failure Treatment Product
Table 113. Cardiorentis Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 114. Cardiorentis Recent Development
Table 115. Cytokinetics Company Details
Table 116. Cytokinetics Business Overview
Table 117. Cytokinetics Heart Failure Treatment Product
Table 118. Cytokinetics Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 119. Cytokinetics Recent Development
Table 120. Ono Pharmaceuticals Company Details
Table 121. Ono Pharmaceuticals Business Overview
Table 122. Ono Pharmaceuticals Heart Failure Treatment Product
Table 123. Ono Pharmaceuticals Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 124. Ono Pharmaceuticals Recent Development
Table 125. Mylan Company Details
Table 126. Mylan Business Overview
Table 127. Mylan Heart Failure Treatment Product
Table 128. Mylan Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 129. Mylan Recent Development
Table 130. NCPC Company Details
Table 131. NCPC Business Overview
Table 132. NCPC Heart Failure Treatment Product
Table 133. NCPC Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 134. NCPC Recent Development
Table 135. Xinhua Group Company Details
Table 136. Xinhua Group Business Overview
Table 137. Xinhua Group Heart Failure Treatment Product
Table 138. Xinhua Group Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 139. Xinhua Group Recent Development
Table 140. Xudong Haipu Pharmaceutical Company Details
Table 141. Xudong Haipu Pharmaceutical Business Overview
Table 142. Xudong Haipu Pharmaceutical Heart Failure Treatment Product
Table 143. Xudong Haipu Pharmaceutical Revenue in Heart Failure Treatment Business (2016-2021) & (US$ Million)
Table 144. Xudong Haipu Pharmaceutical Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Heart Failure Treatment Market Share by Type: 2020 VS 2027
Figure 2. Drug Treatment Features
Figure 3. Surgical Treatment Features
Figure 4. Global Heart Failure Treatment Market Share by Application: 2020 VS 2027
Figure 5. Acute Heart Failure Case Studies
Figure 6. Chronic Heart Failure Case Studies
Figure 7. Heart Failure Treatment Report Years Considered
Figure 8. Global Heart Failure Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Heart Failure Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Heart Failure Treatment Market Share by Regions: 2020 VS 2027
Figure 11. Global Heart Failure Treatment Market Share by Regions (2022-2027)
Figure 12. Global Heart Failure Treatment Market Share by Players in 2020
Figure 13. Global Top Heart Failure Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Heart Failure Treatment as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Heart Failure Treatment Revenue in 2020
Figure 15. Global Heart Failure Treatment Revenue Market Share by Type (2016-2021)
Figure 16. Global Heart Failure Treatment Revenue Market Share by Type (2022-2027)
Figure 17. North America Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Heart Failure Treatment Market Share by Type (2016-2027)
Figure 19. North America Heart Failure Treatment Market Share by Application (2016-2027)
Figure 20. North America Heart Failure Treatment Market Share by Country (2016-2027)
Figure 21. United States Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Heart Failure Treatment Market Share by Type (2016-2027)
Figure 25. Europe Heart Failure Treatment Market Share by Application (2016-2027)
Figure 26. Europe Heart Failure Treatment Market Share by Country (2016-2027)
Figure 27. Germany Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Heart Failure Treatment Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Heart Failure Treatment Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Heart Failure Treatment Market Share by Region (2016-2027)
Figure 37. China Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Heart Failure Treatment Market Share by Type (2016-2027)
Figure 45. Latin America Heart Failure Treatment Market Share by Application (2016-2027)
Figure 46. Latin America Heart Failure Treatment Market Share by Country (2016-2027)
Figure 47. Mexico Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Heart Failure Treatment Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Heart Failure Treatment Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Heart Failure Treatment Market Share by Country (2016-2027)
Figure 53. Turkey Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Heart Failure Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Pfizer Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 57. Novartis Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 58. Merck Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 59. Sanofi Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 61. AstraZeneca Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 62. GlaxoSmithKline Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 64. Bayer Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 65. BMS Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 66. Cardiorentis Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 67. Cytokinetics Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 68. Ono Pharmaceuticals Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 69. Mylan Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 70. NCPC Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 71. Xinhua Group Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 72. Xudong Haipu Pharmaceutical Revenue Growth Rate in Heart Failure Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の心不全検査市場規模・現状・予測（2021年-2027年） Heart failure is due to the contraction of the heart function and (or) diastolic function obstacle, blood vein change can not be fully out of the heart, lead to venous blood pooling system, arterial blood perfusion system is insufficient, causing cardiovascular disorders, the disorder syndrome focus…- 世界の心不全治療薬市場規模・現状・予測（2021年-2027年） Heart failure (HF), often referred to as congestive heart failure (CHF), is when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling.The shortness of breath is usually…
- 世界の高血圧＆心不全治療薬市場規模・現状・予測（2021年-2027年） Hypertension and Heart Failure Drugs such as β-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as first-line agents to c…
- 急性心不全(AHF)治療薬のグローバル市場調査 2019年 The global Acute Heart Failure (AHF) Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Heart Failure (AHF) Therapeutics volume and value at global level, regional level and company …
- 世界の急性＆慢性肝不全市場規模・現状・予測（2021年-2027年） Acute-on-chronic liver failure is a syndrome that affects patients with chronic liver disease; is characterized by intense systemic inflammation, organ failure, and a poor prognosis; and frequently develops in close association with precipitating events. There is no specific treatment for patients w…